Xylem Laboratory System Enables Online Monitoring and Control of Bioreactors - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Xylem Laboratory System Enables Online Monitoring and Control of Bioreactors

Equipment and Processing Report

Xylem's 2900M Online Monitoring and Control System includes an online sampler, analyzer, and controller for laboratory bioreactors. The YSI Sitini Online Sampler from Xylem can be set up to automatically draw fluids from

the bioreactor, delivering samples directly to the 2900 biochemistry analyzer for testing. Sampling is done aseptically with no risk of contamination, as lines are flushed and antiseptic is kept in them after each drawing.

The analyzer measures glucose, glutamine, glutamate, lactate, and other analytes, with accurate results in less than one minute. The components of the 2900M system are autoclavable. The analyzer and the Sitini Sampler can also connect to process management instruments via RS232, ethernet, or OPen Connectivity (OPC) to incorporate into existing applications, and the searchable database allows for quick access to stored results.

Source: Xylem Analytics

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
Source: Equipment and Processing Report,
Click here